Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin in Advanced Cervical Cancer
NCT04294836Phase 2Withdrawn
- Sponsor
- Instituto Nacional de Cancerología
- Start
- Dec 2021
- Primary completion
- Jan 2023
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of Biocurcumax in Cervical Cancer (CC), sponsored by Instituto Nacional de Cancerología. Planned start Dec 2021; status: withdrawn.
02
Drugs
Biocurcumax
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT04294836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04294836.